| # | Drug | Count |
|---|---|---|
| 0 | IRBESARTAN | 283 |
| 1 | METFORMIN | 279 |
| 2 | ESOMEPRAZOLE MAGNESIUM | 276 |
| 3 | SITAGLIPTIN | 269 |
| 4 | ALISKIREN HEMIFUMARATE | 254 |
| 5 | ASPIRIN | 252 |
| 6 | ASPIRIN 325 MG | 251 |
| 7 | ASPIRIN 81 MG | 251 |
| 8 | ESOMEPRAZOLE | 251 |
| 9 | ATORVASTATIN CALCIUM | 245 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAL TAR | 181 | 0.2357 |
| 1 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | 1 | 0.1000 |
| 2 | ALISKIREN HEMIFUMARATE | 254 | 0.0427 |
| 3 | ACITRETIN | 186 | 0.0388 |
| 4 | METHYLPREDNISOLONE ACETATE | 141 | 0.0181 |
| 5 | SITAGLIPTIN PHOSPHATE | 44 | 0.0168 |
| 6 | DIMENHYDRINATE | 163 | 0.0157 |
| 7 | ESOMEPRAZOLE SODIUM | 27 | 0.0115 |
| 8 | ESOMEPRAZOLE MAGNESIUM DIHYDRATE | 145 | 0.0102 |
| 9 | PREDNISOLONE SODIUM PHOSPHATE | 23 | 0.0096 |
| # | Drug class | Count |
|---|---|---|
| 0 | Angiotensin 2 Receptor Blocker [EPC] | 293 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 265 |
| 2 | Proton Pump Inhibitor [EPC] | 260 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 252 |
| 4 | Corticosteroid [EPC] | 186 |
| 5 | Retinoid [EPC] | 186 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 185 |
| 7 | Vitamin B12 [EPC] | 185 |
| 8 | Interleukin-17A Antagonist [EPC] | 183 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 182 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 1 | 0.0057 |
| 1 | Phenothiazine [EPC] | 158 | 0.0054 |
| 2 | Dietary Cholesterol Absorption Inhibitor [EPC] | 163 | 0.0019 |
| 3 | Interleukin-12 Antagonist [EPC] | 164 | 0.0016 |
| 4 | Histamine-1 Receptor Antagonist [EPC] | 128 | 0.0016 |
| 5 | Serotonin-3 Receptor Antagonist [EPC] | 160 | 0.0012 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 36 | 0.0012 |
| 7 | Interleukin-17A Antagonist [EPC] | 183 | 0.0009 |
| 8 | Expectorant [EPC] | 165 | 0.0008 |
| 9 | Thiazide Diuretic [EPC] | 170 | 0.0008 |